FNA News and Press, Paragon 28 Inc. From 02/06/25

2025-02-06 10:21:16 ET More on Zimmer Biomet Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook Zimmer Biomet Non-GAAP EPS of $2.31 beats by $0.02, revenue of $2.02B beats by $10M Zimmer Biomet Q4 2024 Earnings Preview Seeking Alpha’s Quant R...

Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results PR Newswire Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency 1 basis Fourth quarter diluted earnings per share were $1.20 ; adjusted 1 dilut...

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates NARI, FNA, AZPN, TURN on Behalf of Shareholders PR Newswire NEW YORK , Feb. 3, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations ...

2025-02-01 18:45:00 ET More on Health Care Select Sector SPDR® Fund ETF XLV: Healthcare Stocks In Critical Condition (Rating Downgrade) Healthcare Industry Outlook For Trump Admin What S&P sector correlations are telling us about the stock market, according ...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc. PR Newswire NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of direct...

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates FNA, AXL, STAF, QTRX on Behalf of Shareholders PR Newswire NEW YORK , Jan. 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paragon 28, Inc. (NYSE: FNA) to Zimmer Biomet Holdings, Inc. for $13.00 per share in cash is fair to Paragon 28 shareholders. Paragon 28 shareholders will also receive a non-tradeable contingent value right entitl...

2025-01-29 00:46:36 ET Zimmer Biomet ( NYSE: ZBH ) to acquire Paragon 28 ( NYSE: FNA ) for approximately $1.1B to expand its portfolio in the orthopedic surgical device market. Paragon 28 is Colorado-based medical device company focused exclusively on the foot and ankle ...

Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28 PR Newswire Demonstrates Zimmer Biomet's Commitment to Investing in Higher Growth End-Markets, with Expansion into ~$5 Billion Foot and Ankle Segment Expected to Enhance Zimmer Biomet's Financial ...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 22, 2025) - Grabar Law Office is actively investigating claims on behalf of shareholders of Paragon 28, Inc. (NYSE: FNA). Current shareholders who acquired Paragon 28 Inc. (NYSE: FNA) shares prior to May 5, 2023, can seek corporate reforms, ...